// App-Quantinova.ai

580 2014 ATVB : Lung Cancer Chemotherapy Agents Increase Procoagulant Activity via Protein Disulfide Isomerase-Dependent Tissue Factor Decryption

Researchers

Presenter

  • Laura Swystun

Principal Investigators

  • Sara Kuruvilla

  • Andrew Arnold

  • Patricia Liaw

Medical Centers

  • Queens Univ, Kingston, ON, Canada

  • London Health Sciences Center, London, ON, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

  • Coagulation Factor III, Tissue Factor

  • Glutathione

  • Thomsen-Friedenreich antigen

Drug/Treatment

  • Phosphatidylserine

  • Carboplatin

  • Gemcitabine

  • glutathione

  • Paclitaxel

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim